North America Vascular Patches Market Size, Share & Industry Trends Analysis Report By Material (Biologic and Synthetic), By End User (Hospitals and Ambulatory Surgical Centers), By Application, By Country and Growth Forecast, 2022 - 2028

The North America Vascular Patches Market should witness market growth of 6.4% CAGR during the forecast period (2022-2028).

The market's progress is being greatly aided by the growing amount of R&D activities in the production of vascular patches. An article titled 'Tissue-engineered in-vitro vascular patch fabrication using hybrid 3D printing and electrospinning, ' which was published in the journal Materials.

Today Bio in April 2022, for instance, indicated that cutting-edge hybrid 3D printing biotechnology has the opportunity for widespread use in regenerative medicine and possibly in the prevention of heart disease. The patient-specific vascular patches had an appropriate hemodynamic profile, mechanical characteristics, infiltration of generated vascular smooth muscle cells, survival, and functionality.

Such investigations are likely to accelerate market expansion. The rising demand for vascular patch use throughout hospitals is brought on by the high frequency of stroke and ischemic heart disease, which result in a significant number of hospital admissions. Around the world, many carotid endarterectomies are carried out.

Each year, the United States spends a large portion of its GDP on healthcare. The United States spent roughly 17.8% of its total GDP on healthcare in 2021, according to data on health spending from the Organization for Economic Co-operation and Development (OECD) that was published in 2022. This has sparked regional study and development and raised public awareness of vascular patches.

The US market dominated the North America Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $144, 833.2 Thousands by 2028. The Canada market is poised to grow at a CAGR of 8.4% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8.2% during (2022-2028).

Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.

Scope of the Study

By Material

• Biologic
• Synthetic

By End-user

• Hospitals
• Ambulatory Surgical Centers

By Application

• Carotid Endarterectomy
• Open Repair of Abdominal Aortic Aneurysm
• Vascular Bypass Surgery
• Congenital Heart Disease
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Edwards Lifesciences Corporation
• Baxter International, Inc.
• Lemaitre Vascular, Inc.
• Becton, Dickinson and Company
• Terumo Corporation
• Aziyo Biologics, Inc.
• Getinge AB
• B.Braun Melsungen AG
• Artivion, Inc. (CryoLife, Inc.)
• W.L. Gore & Associates, Inc.

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free